“ChatGPT for doctors.” That’s what startup OpenEvidence is quickly becoming known as.

Founded in 2022, OpenEvidence started with a simple idea: “information retrieval,” Travis Zack, chief medical officer at the company, told Healthcare Brew at the 2025 HLTH conference.

There’s a seemingly endless supply of high-quality health research out there from peer-reviewed sources like the Lancet and Nature Medicine. When clinicians need answers for patients, they often turn to these sources.

OpenEvidence is meant to make it easier and faster for them to find that reputable information. It’s similar to tools like DxGPT, developed by tech nonprofit Foundation 29, which was built off Chat GPT-4. ​​As generative AI has improved in the last few years, Zack said, it became easier to create a tool providers could use.

Two years ago, he said he was drawn to the company’s mission of making “clinical practice better” and not simply “more efficient”—plus, it was dedicated to making everything free to boost accessibility since it’s supported by ads.

See more on how the tool works here.—CM

Whether you’re a medical provider, manufacturer, researcher, or just a person who relishes hearing about other people’s mistakes, you need to know about some of the past month’s FDA medical device recalls.

The FDA categorizes recalls—which can range from small corrections to pulling products from use—from Class III (least dangerous) to Class I (most dangerous). We keep you informed on some of those Class I recalls here in our monthly noncomprehensive roundup series.

Without further ado, welcome to Recall Roundup.

Anesthesia issue. Medline has warned customers to destroy affected lots of its anesthesia circuit kits, plus other convenience kits containing anesthesia circuits, after the company got “multiple complaints” of cracks in the circuit’s expandable tubing. This can cause anesthesia to leak into the operating room, per the FDA.

See the full list here.—CC

Each week, we schedule our rounds with Healthcare Brew readers. Want to be featured in an upcoming edition? Click here to introduce yourself.

This week’s Making Rounds spotlights Landon Grace, co-founder and CEO of virtual eye care platform Lumata Health. In March, Lumata raised $23 million in Series B funding from venture firms including McKesson Ventures, LRVHealth, and Cencora Ventures.

Grace talked with Healthcare Brew about being a hands-on CEO, how data is reshaping healthcare, and switching from a reactive to proactive model of care.

How would you describe your job to someone who doesn’t work in healthcare?

My background is in aerospace engineering and I’m also a pilot, so I naturally think in terms of systems and navigation. I see my role as CEO a lot like air traffic control. Our job at Lumata Health is to help patients with chronic eye disease get from point A (being diagnosed with a chronic eye condition) to point B (living a full life while maintaining their vision).

See the full conversation here.—MA